Systematic review of the association between circulating interleukin-6 (IL-6) and cancer
- 1 May 2008
- journal article
- review article
- Published by Elsevier in European Journal Of Cancer
- Vol. 44 (7) , 937-945
- https://doi.org/10.1016/j.ejca.2008.02.047
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- Clustered Environments and Randomized Genes: A Fundamental Distinction between Conventional and Genetic EpidemiologyPLoS Medicine, 2007
- Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort studyBMJ, 2007
- Polymorphisms in Inflammation-related Genes and Risk of Gastric Cancer (Finland)Cancer Causes & Control, 2006
- The role of IL-6 and STAT3 in inflammation and cancerEuropean Journal Of Cancer, 2005
- Circulating Levels of Inflammatory Markers and Cancer Risk in the Health Aging and Body Composition CohortCancer Epidemiology, Biomarkers & Prevention, 2005
- Correlation between tumor necrosis factor-alpha and d-dimer levels in non-small cell lung cancer patientsLung Cancer, 2004
- STAT proteins: From normal control of cellular events to tumorigenesisJournal of Cellular Physiology, 2003
- PREOPERATIVE PLASMA LEVELS OF INTERLEUKIN-6 AND ITS SOLUBLE RECEPTOR PREDICT DISEASE RECURRENCE AND SURVIVAL OF PATIENTS WITH BLADDER CANCERJournal of Urology, 2002
- REDUCTION IN SERUM IL-6 AFTER VACINATION OF BREAST CANCER PATIENTS WITH TUMOUR-ASSOCIATED ANTIGENS IS RELATED TO ESTROGEN RECEPTOR STATUSCytokine, 2000
- Relationship of serum levels of interleukin-6, soluble interleukin-6 receptor and tumour necrosis factor receptors to the acute-phase protein response in advanced pancreatic cancerClinical Science, 1999